The WHO rules persuade the adoption of these systems, delivered they are often validated to display equivalent or outstanding performance in comparison with traditional procedures. Manufacturers planning to put into action these methods have to deliver sturdy validation details to demonstrate their equivalence to pharmacopoeial approaches.